Assure Tech Hangzhou Co Ltd (688075) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Assure Tech Hangzhou Co Ltd (688075) has a cash flow conversion efficiency ratio of 0.000x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-2.25 Million ≈ $-329.31K USD) by net assets (CN¥5.16 Billion ≈ $754.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Assure Tech Hangzhou Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.
Assure Tech Hangzhou Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Assure Tech Hangzhou Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Assure Tech Hangzhou Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Assure Tech Hangzhou Co Ltd ranked by their cash flow conversion efficiency. Explore Assure Tech Hangzhou Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Petpal Pet Nutrition Technology Co Ltd
SHE:300673
|
0.013x |
|
Sebang Global Battery Co Ltd
KO:004490
|
0.042x |
|
Ennis Inc
NYSE:EBF
|
0.054x |
|
ATCO Ltd.
TO:ACO-Y
|
0.047x |
|
Olympic Steel Inc
NASDAQ:ZEUS
|
-0.009x |
|
Zhejiang Starry Pharm Co Ltd
SHG:603520
|
0.004x |
|
Jindal Worldwide Limited
NSE:JINDWORLD
|
0.100x |
|
Sicher Elevator Co. Ltd.
SHE:301056
|
N/A |
Annual Cash Flow Conversion Efficiency for Assure Tech Hangzhou Co Ltd (2017–2025)
The table below shows the annual cash flow conversion efficiency of Assure Tech Hangzhou Co Ltd from 2017 to 2025. View latest Assure Tech Hangzhou Co Ltd stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥5.16 Billion ≈ $755.16 Million |
CN¥-9.41 Million ≈ $-1.38 Million |
-0.002x | -112.62% |
| 2024-12-31 | CN¥5.20 Billion ≈ $760.89 Million |
CN¥75.09 Million ≈ $10.99 Million |
0.014x | +111.83% |
| 2023-12-31 | CN¥5.11 Billion ≈ $747.13 Million |
CN¥-623.08 Million ≈ $-91.18 Million |
-0.122x | -117.67% |
| 2022-12-31 | CN¥5.42 Billion ≈ $792.94 Million |
CN¥3.74 Billion ≈ $547.76 Million |
0.691x | +166.38% |
| 2021-12-31 | CN¥2.61 Billion ≈ $381.41 Million |
CN¥675.94 Million ≈ $98.91 Million |
0.259x | -65.05% |
| 2020-12-31 | CN¥811.69 Million ≈ $118.78 Million |
CN¥602.20 Million ≈ $88.12 Million |
0.742x | +519.59% |
| 2019-12-31 | CN¥162.36 Million ≈ $23.76 Million |
CN¥19.44 Million ≈ $2.84 Million |
0.120x | +0.89% |
| 2018-12-31 | CN¥102.68 Million ≈ $15.02 Million |
CN¥12.19 Million ≈ $1.78 Million |
0.119x | -54.33% |
| 2017-12-31 | CN¥63.54 Million ≈ $9.30 Million |
CN¥16.51 Million ≈ $2.42 Million |
0.260x | -- |
About Assure Tech Hangzhou Co Ltd
Assure Tech (Hangzhou) Co., Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents, and instruments in China and internationally. The company is involved in POCT and plastic product manufacturing; online sales; pharmaceutical manufacturing and sales; and medical testing. It also offers drug of abuse, infectious disease, fertility, cardiac marker, tumor mar… Read more